Support our Foundation of Myology project
1722 news items
Cases of spontaneous remission of autoimmune necrotizing myopathy
On 27/03/2026
An international consortium of clinicians, including researchers from the Institute*, examined specific cases of statin-associated autoimmune necrotizing myopathy (IMNM), particularly those involving anti-HMGCR autoantibodies: four…
Chemical inhibition of SUMOylation activates the FSHD locus
On 26/03/2026
Researchers in Marseille, in collaboration with a researcher from the Institute of Myology*, have investigated the epigenetic regulation of DUX4 expression—the protein responsible for muscle…
Improved efficacy of ERT in pediatric forms of Pompe disease due to newborn screening
On 26/03/2026
A growing number of countries, including the United States, have implemented newborn screening for Pompe disease. American clinicians review the cases of children screened and…
Caution is advised with certain herbal supplements in patients with autoimmune diseases
On 25/03/2026
American doctors have examined the potential risks of over-the-counter herbal products due to their impact on the immune systems of patients with autoimmune conditions such…
The use of autologous CD19 CAR-T cells in refractory autoimmune diseases
On 25/03/2026
A European consortium of researchers reviews the therapeutic use of genetically modified autologous T cells (CAR-T cells): this autologous cell therapy was administered to patients…
The sarcoglycanopathies pattern in whole-body muscle imaging
On 24/03/2026
An international research consortium has reported magnetic resonance imaging (MRI) data (whole-body MRI in this case) from 64 patients diagnosed with sarcoglycanopathy: 43 had LGMD-R3…
How to respond to hyperkinase: recommendations from the European Academy of Neurology
On 23/03/2026
The European Academy of Neurology (EAN), the leading European professional body in neurology, has brought together experts to discuss the diagnostic approach to be adopted…
ERN EURO-NMD webinar, 26 March: Dr. Philip Henman (UK)
On 23/03/2026
Orthopaedic Complications Thursday 26 March 2026 – 16:00-17:00 Paris time Dr. Philip Henman (The Newcastle upon Tyne Hospitals NHS Foundation Trust, UK) > + infos…
An unusual presentation of congenital myasthenic syndrome
On 20/03/2026
Clinicians in Hong Kong report an unusual case of congenital myasthenic syndrome (CMS) that initially suggested an eating disorder: the patient was 42 years old…
Aly Bourguiba winner of the 2026 Graine de Chercheur Prize
On 18/03/2026
Aly Bourguiba is currently a third-year PhD student in the ‘Maintaining muscle mass and function – optimising AAV-based gene therapies (MOOVE)’ team, led by France…
ERN EURO-NMD webinar, 19 March: Prof. Michael Benatar (USA)
On 16/03/2026
Advances in understanding pre-symptomatic ALS: implications for disease prevention Thursday 19 March 2026 – 16:00-17:00 Paris time Prof. Michael Benatar (University of Miami, USA) > +…
TK2 deficiency: from the treatment of early-onset forms to understanding the natural history of late-onset forms
On 13/03/2026
In January 2026, the European Medicines Agency (EMA) issued a favourable opinion on granting marketing authorisation (MA) for Kygevvi (doxecitine and doxribtimine) for the treatment…
Increasing efficacy of Elevidys in DMD
On 10/03/2026
L’essai de phase III EMBARK avait présenté des résultats non significatifs contre placebo pour le critère principal à un an, ce qui avait valu un avis défavorable de l’Agence…
An increased risk of urinary disorders in cases of autoimmune myasthenia
On 10/03/2026
In order to study immune disorders in autoimmune myasthenia gravis, a recent study compared 86 patients with the disease and 90 hospitalized controls, matched for…
Enhancing diagnosis delivery in NMDs: insights from patient experiences
On 09/03/2026
The disclosure of a diagnosis is a pivotal event in a patient’s care pathway and has been the subject of extensive research across various medical…
A football legends’ match in benefit of ALS research
On 09/03/2026
The Institut de Myologie Association is partnering with AS SAINT-ÉTIENNE, the organiser of the Match of the Heroes, which will take place on 31 May…
ERN EURO-NMD webinar, 12 March: Prof. Martin Turner (UK)
On 09/03/2026
EXPERTS-ALS – a Bayesian biomarker-led drug screening platform in ALS Thursday 12 March 2026 – 16:00-17:00 Paris time Prof. Martin Turner (University of Oxford, UK) >…
A pregnancy documented in SMA type I
On 09/03/2026
A retrospective study describes eight pregnancies in six women with severe SMA, who were all wheelchair-dependent, including one case of type I SMA. The three…
Neurodevelopmental disorders in children with treated SMA type I: a point of attention
On 06/03/2026
Around twenty international experts on SMA gathered at a workshop organised by the European Neuromuscular Centre (ENMC) to review the neurodevelopmental disorders observed in a…
Pharmaceutical companies call for greater flexibility in assessing the toxicity of AAV-mediated gene therapy
On 06/03/2026
The question of the duration of clinical and biological monitoring after gene therapy remains under debate, particularly beyond 18 months: a survey was conducted among…
